Company Profile
Quantum Leap Healthcare
Company Overview
About QLHC:
Quantum Leap Healthcare Collaborative (QLHC) is a 501c(3) charitable organization that develops and implements innovative trial designs and rapid-cycle learning through patient centered solutions and the integration of care and research. Founded by leaders recognized for innovative approaches to seemingly intractable problems, QLGC pursues multi-disciplinary initiatives and demonstration projects, including transformative clinical trial models that drive healthcare value and improve outcomes.
Our mission is to create and implement more effective and efficient ways to deliver high quality, patient-focused healthcare. Our founders, Board of Directors, staff, collaborators and the patients we serve, have in the aggregate, unmatched experience in developing innovative approaches, methodologies and models that unite clinical research and healthcare delivery to ensure patient benefit. Our work is cutting edge, often disruptive, and our flagship programs are extendable to many forms of cancer and other diseases.
QLHC is the sponsor of the I-SPY TRIAL, a national Adaptive Platform Trial researching neoadjuvant treatments for early stage, high-risk breast cancers.
Company History
A 501C(3) charitable organization, Quantum Leap Healthcare Collaborative was established in 2005 as a collaboration between medical researchers at University of California, San Francisco and Silicon Valley entrepreneurs. Our mission is to integrate high-impact research with clinical processes and systems technology, resulting in improved data management and information systems, greater access to clinical trial matching and sponsorship, and greater benefit to providers, patients and researchers. Our goal is to improve and save lives.
The founders of QLHC recognize that good ideas and research projects in a University setting were often “orphaned” at the end of a research project. These efforts were frequently left with no funds or organizational structure to adequately engage clinical providers and ultimately benefit patient care. In addition, the intellectual property often created as part of these research endeavors remain untapped and undeveloped.
Modeled after Silicon Valley’s entrepreneurial culture with an added social value objective, our social-entrepreneurial model embodies:
Identifying clinical and research efforts with a potential for high impact
Providing financial and managerial assistance
Forming organizations and management teams to grow proven ideas into products
Securing funding in stages as efforts mature
Creating strategic partnerships committed to developing high-value healthcare services and products
We support the development and implementation of innovative ways to deliver better, less costly healthcare. We are committed to establishing unique collaborations across the medical, technology and bioscience industries: all necessary components to accelerate healthcare research into the marketplace. Our efforts focus on quality-of-care and quality-of-life issues, and to create initiatives that foster excellent clinical practices using quality improvement disciplines with a strong patient-centric focus.
Notable Accomplishments / Recognition
We support the development and implementation of innovative ways to deliver better, less costly healthcare. We are committed to establishing unique collaborations across the medical, technology and bioscience industries: all necessary components to accelerate healthcare research into the marketplace. Our efforts focus on quality-of-care and quality-of-life issues, and to create initiatives that foster excellent clinical practices using quality improvement disciplines with a strong patient-centric focus.